Our 2 dose critical trial showed better results (m

Our 2 dose critical trial showed better results (more than 30% reduction in mortality) than any COVID treatment for this cohort in the world. And unlike intubation + Remdesivir, Leronlimab doesn't kill half the patients it treats. With no SAE's - and no viable optional treatment for the critically ill - it's an absolute no brainer to approve a drug like Leronlimab for those on death's door. As the head of the FDA said herself in the fall of 2020, we should not be held hostage to a P value during a pandemic if the drug in question has a good safety profile.

As for the judge and hospital doctors not approving the literal death's-bed wish of a wife for her husband to receive one of the safest, most tested drugs in the world - a drug with more than 60 clinical studies that show a greater than 65% success rate ...compared to intubation and remdesivir? Evil. The judge and hospital doctors displayed cold-blooded evil.